Please login to the form below

Not currently logged in
Email:
Password:

Response to the COVID-19 Pandemic Crisis – special category for 2021

Sponsored by

  • Full Results
    • Winner

      On the Front Line - Behind Extraordinary Achievement You'll Always Discover Extraordinary Collaboration

      by National Clinical Homecare Association (NCHA) and the National Homecare Medicines Committee (NHMC)


      Finalists

      New Normal, Same Cancer

      by AstraZeneca
      with support from GCI Health and Engine MHP

      NRAS Patient Chatbot

      by National Rheumatoid Arthritis Society (NRAS)
      with support from earthware


Back to Results


Winner

On the Front Line - Behind Extraordinary Achievement You'll Always Discover Extraordinary Collaboration

by National Clinical Homecare Association (NCHA) and the National Homecare Medicines Committee (NHMC)


Summary of work

NCHA is the UK trade body for the Clinical Homecare Industry representing the majority of organisations providing Clinical Homecare Services. Currently, approximately 463,000 UK patients receive Clinical Homecare Services. Homecare patients receive hospital-led care in community settings and many patients choose to be treated at home rather than in hospital or as outpatients. Clinical Homecare is often associated with high-cost drug treatments and in 2019 - 20 accounted for £2.1bn or 30% (Pre-COVID) of the NHS secondary care medicines budget.
The NCHA is at the forefront of ensuring high standards are applied across the industry working closely across NHMC, and the NHS.
NHMC is a national committee comprising of NHS and Industry representatives. The key aim of NHMC is to act as the national focus for developing and improving processes for homecare medicines services. It advises the NHS on matters relating to homecare and collaboratively works with industry to support best practice.
Homecare medicines service is defined as a service that delivers ongoing medicine supplies, and where necessary, associated care, initiated by the hospital prescriber, direct to the patient’s home with consent. The purpose of the homecare medicines service is to improve patient care and choice of their clinical treatment.

Judges' comments

This entry from NCHA and NHMC was superb! It was highly collaborative, innovative and very quick off the mark. The feedback from the NHS was impressive and the execution was outstanding. The scale was impressive, whilst working in a very flexible and agile way with lasting changes. It quite simply changed the game in terms of how many patients are managed going forward.


Finalists

New Normal, Same Cancer - by AstraZeneca
with support from GCI Health and Engine MHP

NRAS Patient Chatbot - by National Rheumatoid Arthritis Society (NRAS)
with support from earthware


Key dates

Entry deadline 26 August 2021
Extended entry deadline 2 September 2021*
*additional fee applies
Judging Day 1 October 2021
Company of the Year Interviews 22 October 2021
PMEA Event 24 November 2021